We are live on ! Find out more
GH icon

Guardant Health

398 hedge funds and large institutions have $7.73B invested in Guardant Health in 2025 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 135 increasing their positions, 134 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 38

50% more funds holding in top 10

Funds holding in top 10: 6 → 9 (+3)

8% more funds holding

Funds holding: 367 → 398 (+31)

1% more repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 134

2% less capital inflows, than outflows

Capital inflows: $1.02B | Capital outflows: $1.04B

10% less call options, than puts

Call options by funds: $156M | Put options by funds: $173M

1.09% less ownership

Funds ownership: 100.34% → 99.25% (-1.1%)

Holders
398
Holders Change
+31
Holders Change %
+8.45%
% of All Funds
5.19%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
71
Increased
135
Reduced
134
Closed
38
Calls
$156​M
Puts
$173​M
Net Calls
-⁠$16.8​M
Net Calls Change
+$20.6​M

GH Hedge Fund Activity: Q3 2025 in Review

398 of the 7,665 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q3 2025, worth a combined $7.73B — up 20% from $6.47B a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new GH positions and 38 closed out — a net gain of 33 holders — while 135 added to existing stakes and 134 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $134M. The largest seller was Citadel Advisors, cutting an estimated $143M.

  • 398 institutional investors held Guardant Health (GH) as of Q3 2025, up from 367 in Q2 2025.
  • Funds reported $7.73B of Guardant Health stock for Q3 2025, up 20% quarter-over-quarter.
  • 71 funds opened new Guardant Health positions in Q3 2025 and 38 closed out, a net change of +33 holders.
  • The largest Guardant Health buyer in Q3 2025 was T. Rowe Price Associates, an estimated $134M added.
  • The largest Guardant Health seller in Q3 2025 was Citadel Advisors, an estimated $143M sold.

Based on aggregated 13F filings for Q3 2025.